Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances